Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19)

NCT04416100 · clinicaltrials.gov ↗

UNKNOWN

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Covid-19
Pulmonary Fibrosis

Interventions

DIAGNOSTIC_TEST: Pulmonary function tests
DIAGNOSTIC_TEST: Imaging
BIOLOGICAL: Blood sampling

Sponsor

Medical University Innsbruck

Collaborators

[object Object]